Has Nicholas Pastis, MD received payments from drug or device companies?

Yes. Drug and device makers reported $144,586 in general payments to Nicholas Pastis, MD across 127 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nicholas Pastis, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nicholas Pastis, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nicholas Pastis, MD

Critical Care Medicine · Columbus, OHNPI 1942203922

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $105,425 of the $144,586 with a category attached, or 72.9%. 16 manufacturers reported payments, led by Johnson & Johnson at 52.2% of the total. Among critical care medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$144,586in general payments, 2019–2025

Across 127 payments — averaging $1138.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$75K
Olympus Corporation Of The Americas$35K
Olympus Corporation$11K
AstraZeneca$8K
Cook Incorporated$8K
Veran Medical Technologies, Inc.$3K
plus $5K from 10 others

$182,079in research payments, 2019–2025

Across 33 payments — averaging $5517.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Johnson & Johnson$130K
Olympus Corporation Of The Americas$39K
Pulmonx Corporation$9K
Concordia Laboratories Inc.$4K
Veran Medical Technologies, Inc.$750

What the payments were for

Consulting fees$105,42573%
Speaking & faculty fees$9,8007%
Travel & lodging$6,8215%
Food & beverage$2,5072%
Education$20,03314%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	9	$75,449
Olympus Corporation Of The Americas	57	$34,709
Olympus Corporation	24	$10,770
AstraZeneca	2	$8,055
Cook Incorporated	2	$7,940
Veran Medical Technologies, Inc.	7	$2,957
Coaptech, Inc.	2	$1,378
Olympus Medical Systems Corporation	1	$880
Olympus America Inc.	6	$739
Intuitive Surgical	4	$592
Cook Medical LLC	3	$414
Steris Corporation	2	$228
Boston Scientific	2	$197
Pulmonx Corporation	3	$175
ERBE USA Inc	1	$61
Pinnacle Biologics, Inc	2	$41

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Monarch Platform$75,436
EVES EUS ULTRASOUND BRONCHOFIBERVIDEOSCOPE$17,010
IMFINZI$8,055
Olympus Capital Accessories$8,051
Olympus EBUS Bronchoscopes$8,051
Olympus Respiratory Accessories$8,051
Single Use Aspiration Needle NA-U401SX$7,860
Olympus Bronchoscopes$7,260
EVIS EXERA$7,260
Blue Rhino$4,170
Melker$4,125
Spin$1,559
PUMA SYSTEM$1,378
Da Vinci Surgical System$544
Single Use Aspiration Needle NA-U200H$440
TRUFREEZE$139
ACQUIRE$120
Pulmonx Endobronchial Valve EBV$101

How this compares

$144,586 in reported general payments places this provider in the 95th percentile of 285 critical care medicine providers in Ohio.

See all critical care medicine providers in Ohio →

Medicare billing

Part B allowed, 2024

$61,838

Medicare patients

194

Services billed

591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate	15	$319

Paid to pharmacies, not to this prescriber.

Other critical care medicine in Columbus

Michael EssandohColumbus$135K
Kari GorderColumbus$20K
Elliott CrouserColumbus$16K
Shailesh PintoColumbus$7K
John ChristmanColumbus$5K
Jennifer JamesColumbus$2K
Jared CollinsColumbus$1K
Neal ChaissonCleveland$428K
Robert SchilzCleveland$356K
Chiedozie UdehCleveland$24K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →